 |
Crescendo Communications is handling IR duties for Silexion Ltd, the Israeli clinical stage oncology-focused biotech that is merging in a SPAC deal with Moringa Acquisition Corp.
The deal, which is expected to close during the third quarter, is valued at $62.5M.
Ilan Levin, CEO of Moringa, said Silexion is on the cutting edge of RNA therapeutics.
Its first-generation Loder product has demonstrated strong results in patients with pancreatic cancer. Loder achieved a median overall survival advantage of 9.3 months over the use of chemotherapy alone.
Levin believes the merger will provide "both our respective shareholders the opportunity to participate in the potential of Silexion’s powerful platform as a public company listed on Nasdaq.”
David Waldman heads New York-based Crescendo, which launched in 2006.
As capital concentrates among established firms, emerging managers must find new ways to earn investor confidence.
Teneo handles True Food Kitchen as the Scottsdale, AZ-based wellness food restaurant chain that counts Oprah Winfrey as a minority investor files for Chapter 11.
FGS Global and Teneo represent Canada’s billionaire Weston family as its Wittington Investments holding company acquires Boots Group, the 177-year-old UK health & beauty retailer, from Sycamore Partners for $8.9B.
Joele Frank handles C.H. Robinson Worldwide as the freight transportation company acquires RXO Inc. in a stock and cash transaction pegged at $5.8B to create a company with an enterprise value of more than $25B.
Brunswick Group handles France’s Schneider Electric as it acquires Boston’s PTC, maker of engineering software, for $22.6B cash.
